Dr. Huma Khan , MD
Allergy & Immunology β’ Houston, TX
18300 Katy Fwy Ste 605
Houston, TX 770941494
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Huma Khan is listed in NPPES under Allergy & Immunology.
-
NPI assigned on June 11, 2019; this date does not establish years in practice.
-
Published CMS data list 35 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Fluticasone Propionate β 35 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 90% of clinicians listed under Allergy & Immunology in Houston, TX (2024, 31 clinicians with data). Median for this group: 472. Middle half: 112 to 758.
Fewer Part D prescriptions than 90% of clinicians listed under Allergy & Immunology in Texas (2024, 228 clinicians with data). Median for this group: 401. Middle half: 162 to 744.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 25 in 2021 to 35 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2021β2024.
Practice Location & Contact Primary Location
18300 Katy Fwy Ste 605
Houston, TX 770941494
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Ent And Allergy Associates Of Texas Pllc; Houston Ear Nose And Throat Clinic Llp. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2017
What Public CMS Data Show
Allergy & Immunology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
47 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$432 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $883.27 across 29 records.
By nature of payment
- Food and Beverage: $883.27 across 29 records.
Reporting-company totals (3 largest of 10)
- AstraZeneca Pharmaceuticals LP: $187.65 across 8 records.
- Sanofi and Genzyme US Companies: $169.29 across 7 records.
- AERIN MEDICAL INC.: $155.45 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
9 years (graduated 2017)
CMS Doctors and Clinicians data list 2017 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2019
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Khan has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Khan as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 90% of clinicians listed under Allergy & Immunology in Houston, TX (2024, 31 clinicians with data). Median for this group: 472. Middle half: 112 to 758.
Fewer Part D prescriptions than 90% of clinicians listed under Allergy & Immunology in Texas (2024, 228 clinicians with data). Median for this group: 401. Middle half: 162 to 744.
Part D drug cost
A lower Part D drug cost than 90% of clinicians listed under Allergy & Immunology in Houston, TX (2024, 31 clinicians with data). Median for this group: $144,919. Middle half: $36,394 to $455,122.
A lower Part D drug cost than 90% of clinicians listed under Allergy & Immunology in Texas (2024, 228 clinicians with data). Median for this group: $119,050. Middle half: $32,459 to $262,419.
42 active clinicians are listed under Allergy & Immunology with a practice address in Houston, TX (331 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
19% of these 42 clinicians have the CMS telehealth indicator.
57.1% of these 42 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 40% from 25 in 2021 to 35 in 2024.
- 2021: 25
- 2023: 11
- 2024: 35
-
30-day fills
30-day fills varied from year to year: 46 in 2021 and 47 in 2024.
- 2021: 46
- 2023: 18
- 2024: 47
-
Part D drug cost
Part D drug cost went from $312 in 2021 to $432 in 2024.
- 2021: $312
- 2023: $303
- 2024: $432
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $17.28 in 2021 to $883.27 in 2025.
- 2021: $17.28
- 2022: $20.66
- 2024: $182.77
- 2025: $883.27
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 29 records totaling $883.27.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AERIN MEDICAL INC. |
Food and Beverage
In-kind items and services
|
VIVAER STYLUS | General | $155.45 |
| Grifols Shared Services North America, Inc. |
Food and Beverage
In-kind items and services
|
Xembify | General | $124.99 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.18 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
β | General | $36.55 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.69 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.41 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $29.34 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $25.82 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
CUVITRU | General | $25.28 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $25.20 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $24.27 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $23.71 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $23.20 |
| ARS Pharmaceuticals Operations, Inc. |
Food and Beverage
In-kind items and services
|
NEFFY | General | $22.05 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $21.99 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $21.93 |
| Optinose US, Inc. |
Food and Beverage
In-kind items and services
|
Xhance | General | $20.69 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $20.65 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $20.20 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $20.18 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $19.95 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $18.76 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $16.66 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $16.37 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $15.44 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Fluticasone Propionate | Fluticasone Propionate | 35 | 1,410 | $431.76 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-04-23NUCC Taxonomy Code: 207K00000X
An allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - ALLERGY/IMMUNOLOGY
I20250115001029
TX
7012241557
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Houston Ear Nose And Throat Clinic Llp
18300 Katy Fwy, Houston, TX 770941385
Phone: 2815781910
Ent And Allergy Associates Of Texas Pllc
18300 Katy Fwy, Houston, TX 770941494
Phone: 2815781910
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Otolaryngology
Doctor of Medicine (M.D.)
Otolaryngology
Doctor of Medicine (M.D.)
Otolaryngology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Internal Medicine (license number reported to NPPES: IL 125073657)
Registered at 18300 KATY FWY STE 605, HOUSTON, TX 770941494 (Tel: 2815781910)
Registered at 14140 SOUTHWEST FWY STE 200, SUGAR LAND, TX 774783842 (Tel: 2816497000)
Allergy & Immunology (license number reported to NPPES: TX V4690)
NPI status registered as active in NPPES database
Registered at 701 N 1ST ST, SPRINGFIELD, IL 627023757 (Tel: 2175458000)
Registered at PO BOX 19636, SPRINGFIELD, IL 627949636 (Tel: 2175458000)
Recorded as HUMA KHAN, MD
Internal Medicine (license number reported to NPPES: IL 125073657)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Allergy & Immunology Specialists in Houston
- Dr. Robert Saunders, MD
- Dr. Juan Zambrano, MD
- Dr. Duyen Nguyen, DO
- Dr. Joud Hajjar, MD
- Dr. Robert Burress, MD
- Theodore Lee
Mailing Address
14140 Southwest Fwy Ste 200
Sugar Land, TX 774783842
Phone: 2816497000